Zota Health Care Ltd.

₹1,087.2

-12.3 (-1.1%)

ZOTA Share Price

Pharmaceuticals & Biotechnology

As on September 11, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,765 Cr

P/E Ratio-50.93

Dividend Yield0.01 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,100.76	Bearish
10-DMA	1,089.73	Bearish
20-DMA	1,089.28	Bearish
50-DMA	1,220.23	Bearish
100-DMA	1,242.21	Bearish
200-DMA	1,299.85	Bearish

Historical Performance

1 Year

-28.2%

3 Years

164.8%

5 Years

193.1%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	5,387	2,930	1,804	1,399	1,312
Total Expenditure	5,209	2,990	1,729	1,332	1,167
Other Income	83	24	12	26	20
Operating Profit	261	-36	87	93	164
Interest	174	108	48	26	3
Depreciation	825	432	201	120	37
Profit Before Tax	-798	-576	-162	-47	124
Consolidated Net Profit	-739	-564	-143	-58	89
Adjusted EPS	-21	-20	-6	-2	4

Compounded Sales Growth

10 Years:44.5

5 Years:38.2

3 Years:30.9

TTM:13

Compounded Profit Growth

10 Years:35.8

5 Years:223.4

3 Years:66.5

TTM:5.6

Stock Price CAGR

10 Years:N/A

5 Years:24.7

3 Years:38.1

TTM:-28.6

Return on Equity

10 Years:N/A

5 Years:3.5

3 Years:-5.6

last year:-21.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	346	286	258	252	252
Total Reserves	6,589	1,950	641	552	645
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,723	1,027	603	361	134
Other Current Liabilities	701	415	191	103	126
Short Term Borrowings	224	6	147	---	---
Total Liabilities	11,058	4,305	2,239	1,570	1,389
Capital Work in Progress	17	56	48	31	---
Long Term Loans & Advances	2	1	1	1	1
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	749	311	218	107	84
Total Current Assets	4,572	1,842	1,116	842	769
Total Assets	11,058	4,305	2,239	1,570	1,389
Adjusted Book Value	200	78	35	32	36

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -50.93, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 39.8%, indicating sustained price appreciation.
The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹261 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹5387 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 724317.1

No. of Shares: 666 (Approx)

Performance:-27.6%

-275682.9

NIFTY Performance: -6.8%

1 day Top Gainers